MHRA reminder for healthcare professionals who administer yellow fever vaccine

30 April 2019

Article: 53/1706

After two reports of fatal adverse reactions to the yellow fever vaccine (Stamaril), the Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning to healthcare professionals who administer the drug.

Due to an increased risk of life-threatening reactions, the vaccine must not be given to anyone with a medical history of thymus dysfunction or who is immunosuppressed.  In addition, extreme caution must be used and a careful risk assessment conducted before vaccination of people aged 60 years and older, due to a substantially increased risk of such adverse reactions in this age group.

Source: MHRA, 16 April 2019